Glial reactions in Parkinson's disease

McGeer, Patrick L., McGeer, Edith G.·2008·Movement Disorders

DOI 10.1002/mds.21751

Cited by (700)

Items 201–300 of 700

Modelling Parkinson‐like neurodegeneration via osmotic minipump delivery of MPTP and probenecid
Daniel Alvarez‐Fischer, Serge Guerreiro, Stéphane Hunot, Françoise Saurini, Marc R. Marien, Pierre Sokoloff, Étienne C. Hirsch, Andreas Hartmann, Patrick Pierre Michel · 2008 · Journal of Neurochemistry
Anti-inflammatory activities and mechanisms of Artemisia asiatica ethanol extract
Deok Jeong, Young‐Su Yi, Gi‐Ho Sung, Woo Seok Yang, Jae Gwang Park, Keejung Yoon, Deok Hyo Yoon, Changsik Song, Yunmi Lee, Man Hee Rhee et al. · 2014 · Journal of Ethnopharmacology
Cutting Edge: IL-13Rα1 Expression in Dopaminergic Neurons Contributes to Their Oxidative Stress–Mediated Loss following Chronic Peripheral Treatment with Lipopolysaccharide
Brad E. Morrison, Maria Cecília Garibaldi Marcondes, Daniel K. Nomura, Manuel Sánchez-Alavez, Alejandro Sánchez-González, Indrek Saar, Kwang‐Soo Kim, Tamás Bartfai, Pamela A Maher, Shuei Sugama et al. · 2012 · The Journal of Immunology
Cytochrome c Oxidase and Its Role in Neurodegeneration and Neuroprotection
Susanne Arnold · 2012 · Advances in experimental medicine and biology
Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia
Ping Zhang, Kyle M. Lokuta, DeAnne E. Turner, Bin Liu · 2009 · Journal of Neurochemistry
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role
Zucca, Fabio A., Capucciati, Andrea, Bellei, Chiara, Sarna, Michał, Sarna, Tadeusz, Monzani, Enrico, Casella, Luigi, Zecca, Luigi · 2023 · IUBMB Life
Anti-inflammatory role of GM1 and other gangliosides on microglia
Danny Galleguillos, Qian Wang, Noam Steinberg, Asifa K. Zaidi, Gaurav Shrivastava, Kamaldeep Dhami, Gour Chand Daskhan, Edward N. Schmidt, Zoë Dworsky-Fried, Fabrizio Giuliani et al. · 2022 · Journal of Neuroinflammation
Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization
Yujeong Lee, Hee Ra Park, Hye Jeong Chun, Jaewon Lee · 2015 · Journal of Neuroscience Research
Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease
Eduardo Anitua, Consuelo Pascual, Rocío Pérez‐González, Gorka Orive, Eva Carro · 2015 · Journal of Controlled Release
Apocynin, a Low Molecular Oral Treatment for Neurodegenerative Disease
Bert A. ‘t Hart, Sjef C.V.M. Copray, Ingrid H.C.H.M. Philippens · 2014 · BioMed Research International
Altered GABAergic Signaling in Brain Disease at Various Stages of Life
Yoo Sung Kim, Bo‐Eun Yoon · 2017 · Experimental Neurobiology
Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation
Kang-Woo Lee, Xin Zhao, Joo‐Young Im, Hilary Grosso, Won Hee Jang, Teresa W. Chan, Patricia K. Sonsalla, Dwight C. German, Hidenori Ichijo, Eunsung Junn et al. · 2012 · PLoS ONE
Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor α in the nigrostriatal dopaminergic circuit of adult mice
Mariela Chertoff, N. Di Paolo, Annette Schöneberg, Amaicha Mara Depino, Carina Cintia Ferrari, Wolfgang Wurst, Klaus Pfizenmaier, Ulrich L.M. Eisel, Fernando Juan Pitossi · 2010 · Experimental Neurology
Modulating Microglia Activity with PPAR-γ Agonists: A Promising Therapy for Parkinson’s Disease?
Anna Rosa Carta, Augusta Pisanu · 2012 · Neurotoxicity Research
Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract
Nadja Van Camp, Ines Blockx, Marleen Verhoye, Cindy Casteels, Frea Coun, Alexander Leemans, Jan Sijbers, Veerle Baekelandt, Koen Van Laere, Annemie Van der Linden · 2009 · NMR in Biomedicine
Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson's disease model
Kazuya Miyanishi, Mohammed Emamussalehin Choudhury, Minori Watanabe, Madoka Kubo, Masahiro Nomoto, Hajime Yano, Junya Tanaka · 2018 · Neurochemistry International
Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats
L.-W. Fan, Asuka Kaizaki, Lu‐Tai Tien, Yi Pang, Sachiko Tanaka, Satoshi Numazawa, Abhay Bhatt, Zhengwei Cai · 2013 · Neuroscience
Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity
Layal Maatouk, Chenju Yi, María-Angeles Carrillo-de Sauvage, Anne‐Claire Compagnion, Stéphane Hunot, Pascal Ezan, Étienne C. Hirsch, Annette Koulakoff, Frank W. Pfrieger, François Tronche et al. · 2018 · Cell Death and Differentiation
Cannabinoids and Parkinsons Disease
Moisés Garcı́a-Arencibia, Concepción García, Javier Fernández‐Ruíz · 2009 · CNS & Neurological Disorders - Drug Targets
Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats
Eun Young Lee, Jeong Eun Lee, Jae Hyeon Park, In Chul Shin, Hyun Chul Koh · 2012 · Toxicology Letters
Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: Role of free radical generation
Ping Zhang, Tamika A. Wong, Kyle M. Lokuta, DeAnne E. Turner, Kristina Vujisic, Bin Liu · 2009 · Experimental Neurology
Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice
Wenhui Qu, Andrea Johnson, Joo Hyun Kim, Abigail Lukowicz, Daniel A. Svedberg, Marija Cvetanović · 2017 · Journal of Neuroinflammation
Modulation of connexin 43 in rotenone-induced model of Parkinson's disease
Akiko Kawasaki, Tomonori Hayashi, Kei Nakachi, James Edward Trosko, Kazumi Sugihara, Yaichiro Kotake, Shinji Ohta · 2009 · Neuroscience
A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia
Martin T. Henrich, Fanni F. Geibl, Bolam Lee, Wei‐Hua Chiu, James B. Koprich, Jonathan M. Brotchie, Lars Timmermann, Niels Decher, Lina A. Matschke, Wolfgang Hermann Oertel · 2018 · Acta Neuropathologica Communications
Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease
Khadija Tayara, Ana M. Espinosa‐Oliva, Irene García-Domínguez, Afrah Abdul Ismaiel, Antonio Boza‐Serrano, Tomas Deierborg, Alberto Machado, Antonio J. Herrera, Jose Luis Venero, Rocío M. de Pablos · 2018 · Frontiers in Cellular Neuroscience
Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region
Erin M. Hill‐Burns, Stewart Alan Factor, Cyrus P. Zabetian, Glenys J. Thomson, Haydeh Payami · 2011 · PLoS ONE
Role of glial cells in manganese neurotoxicity
Nikolay M. Filipov, Celia A. Dodd · 2011 · Journal of Applied Toxicology
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
Juhyun Song, Jongpil Kim · 2016 · Frontiers in Aging Neuroscience
Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration
Russell L. Blaylock · 2017 · Surgical Neurology International
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Ludovica Iovino, Veronica Giusti, Francesca Pischedda, Elena Giusto, Nicoletta Plotegher, Antonella Marte, Ilaria Battisti, Angela Di Iacovo, Algerta Marku, Giovanni Piccoli et al. · 2022 · Acta Neuropathologica
Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases
Claire Gibrat, Francesca Cicchetti · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
l -DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?
Elaine Aparecida Del Bel, Mariza Bortolanza, Maurício dos Santos Pereira, Keila Bariotto‐dos‐Santos, Rita Raisman‐Vozari · 2016 · Synapse
Gene disruption of caspase-3 prevents MPTP-induced Parkinson’s disease in mice
Marina Yamada, Kotaro Kida, Willington Amutuhaire, Fumito Ichinose, Masao Kaneki · 2010 · Biochemical and Biophysical Research Communications
Knocking Out DJ-1 Attenuates Astrocytes Neuroprotection Against 6-Hydroxydopamine Toxicity
Nirit Lev, Yael Barhum, Tali Ben‐Zur, Eldad Melamed, Israel Steiner, Daniel Offen · 2013 · Journal of Molecular Neuroscience
Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide
Asuka Kaizaki, Lu‐Tai Tien, Yi Pang, Zhengwei Cai, Sachiko Tanaka, Satoshi Numazawa, Abhay Bhatt, Lir‐Wan Fan · 2013 · Journal of Neuroinflammation
Growth Factors and Neuroglobin in Astrocyte Protection Against Neurodegeneration and Oxidative Stress
Ricardo Cabezas, Eliana Báez-Jurado, Oscar Hidalgo‐Lanussa, Valentina Echeverrı́a, Ghulam Md Ashrad, Amirhossein Sahebkar, George Emilio Barreto · 2018 · Molecular Neurobiology
Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice
Supriti Samantaray, Varduhi H. Knaryan, Donald C. Shields, April Cox, Azizul Haque, Naren Lal Banik · 2015 · Molecular Neurobiology
Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson’s disease
Gülnur Andican, Dildar Konukoğlu, Melda Bozluolçay, Kemal Bayülkem, Sinem Firtiına, Gülden Burçak · 2012 · Acta Neurologica Belgica
The astrocytic response to the dopaminergic denervation of the striatum
Ingrid Moráles, Alberto Sánchez, Clara Rodriguez‐Sabate, Manuel Rodrı́guez · 2016 · Journal of Neurochemistry
Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming
Ruinan Gu, Fa‐Li Zhang, Gang Chen, Chaojun Han, Jay Liu, Zhaoxiang Ren, Yi Zhu, John L. Waddington, Long Tai Zheng, Xuechu Zhen · 2016 · Brain Behavior and Immunity
PPARγ and Cognitive Performance
Michele d’Angelo, Vanessa Castelli, Mariano Catanesi, Andrea Antonosante, Reyes Dominguez-Benot, Rodolfo Ippoliti, Elisabetta Benedetti, Annamaria Cimini · 2019 · International Journal of Molecular Sciences
Microglia-inhibiting activity of Parkinson's disease drug amantadine
Jong‐Heon Kim, Ho‐Won Lee, Jaegyu Hwang, Jae‐Hong Kim, Min-Jeong Lee, Hyung Soo Han, Won‐Ha Lee, Kyoungho Suk · 2011 · Neurobiology of Aging
Crosstalk between metabolic and neuropsychiatric disorders
Oksana Kaidanovich‐Beilin, Danielle S. Cha, Roger S. McIntyre · 2012 · F1000 Biology Reports
Measuring prions by bioluminescence imaging
Gültekin Tamgüney, Kevin P. Francis, Kurt Giles, Azucena Lemus, Stephen J. DeArmond, Stanley B. Prusiner · 2009 · Proceedings of the National Academy of Sciences
Bezafibrate prevents mitochondrial dysfunction, antioxidant system disturbance, glial reactivity and neuronal damage induced by sulfite administration in striatum of rats: Implications for a possible therapeutic strategy for sulfite oxidase deficiency
Mateus Grings, Alana Pimentel Moura, Belisa Parmeggiani, Julia Tauana Pletsch, Gabriela Miranda Fernandez Cardoso, Pauline Maciel August, Cristiane Matté, Ângela Terezinha de Souza Wyse, Moaçir Wajner, Guilhian Leipnitz · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus
Hitomi Aono, Mohammed Emamussalehin Choudhury, Hiromi Higaki, Kazuya Miyanishi, Yuka Kigami, Kohdai Fujita, Jun-ichi Akiyama, Hisaaki Takahashi, Hajime Yano, Madoka Kubo et al. · 2017 · Glia
Cortical Injury Increases Cholesterol 24S Hydroxylase (Cyp46) Levels in the Rat Brain
Casandra M. Cartagena, Farid A.K.M. Ahmed, Mark P. Burns, Ahdeah Pajoohesh‐Ganji, Daniel T.S. Pak, Alan I. Faden, George William Rebeck · 2008 · Journal of Neurotrauma
Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling
Francesca L’Episcopo, Cataldo Tirolo, Luca Peruzzotti‐Jametti, Maria Francesca Serapide, Nunzio Testa, Salvatore Caniglia, Beatrice Balzarotti, Stefano Pluchino, Bianca Marchetti · 2018 · Stem Cells
Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
Francesca L’Episcopo, Cataldo Tirolo, Salvatore Caniglia, Nunzio Testa, Pier Andrea Serra, Francesco Impagnatiello, Maria C. Morale, Bianca Marchetti · 2010 · Journal of Neuroinflammation
N9 microglial cells polarized by LPS and IL4 show differential responses to secondary environmental stimuli
Hongcui Liu, Min Zheng, Yanling Du, Li Wang, Fang Kuang, Hong‐Yan Qin, Bingfang Zhang, Hua Han · 2012 · Cellular Immunology
Microglial glutamate release evoked by α‐synuclein aggregates is prevented by dopamine
Maurício dos Santos Pereira, Leonardo Acuña, Sabah Hamadat, Jérémy Rocca, Florencia González‐Lizárraga, Rosana Nieves Chehín, Julia Elisa Sepulveda-Diaz, Elaine Aparecida Del Bel, Rita Raisman‐Vozari, Patrick Pierre Michel · 2018 · Glia
Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson’s disease
Cuevas, Elvis, Burks, Susan, Raymick, James, Robinson, Bonnie, Gómez-Crisóstomo, Nancy P., Escudero-Lourdes, Claudia, Lopez, Aida G. Guzman, Chigurupati, Srinivasulu, Hanig, Joseph, Ferguson, Sherry A. et al. · 2022 · Nutritional Neuroscience
Prevention of the degeneration of human dopaminergic neurons in an astrocyte co‐culture system allowing endogenous drug metabolism
Liudmila V. Efremova, Stefan Schildknecht, Martina Adam, Regina Pape, Simon Gutbier, Benjamin Hanf, Alexander Bürkle, Marcel Leist · 2015 · British Journal of Pharmacology
Neuroprotective effects of liraglutide against inflammation through the AMPK/NF-κB pathway in a mouse model of Parkinson’s disease
Bing Cao, Yanqiu Zhang, Jinhu Chen, Pengyue Wu, Yuxuan Dong, Yanqin Wang · 2021 · Metabolic Brain Disease
Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease
Hironori Yokoyama, Hiroto Uchida, Hayato Kuroiwa, Jiro Kasahara, Tsutomu Araki · 2010 · Neurological Sciences
The Antioxidant Effects of Thymoquinone in Activated BV-2 Murine Microglial Cells
Makini K. Cobourne-Duval, Equar Taka, Patricia Mendonca, David Bauer, Karam F. A. Soliman · 2016 · Neurochemical Research
Microglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading
Inês Dinis Aires, Teresa Ribeiro‐Rodrigues, Raquel Boia, Magda Ferreira-Rodrigues, Henrique Girão, António Francisco Ambrósio, Ana Raquel Santiago · 2021 · Biomolecules
Neurotoxic Saboteurs: Straws that Break the Hippo’s (Hippocampus) Back Drive Cognitive Impairment and Alzheimer’s Disease
Mak Adam Daulatzai · 2013 · Neurotoxicity Research
A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2R1441G) transgenic mouse model of Parkinson's disease
Brian P. Dranka, Alison Gifford, Donna M. McAllister, Jacek Zielonka, Joy Joseph, Crystal L. O’Hara, Cheryl L. Stucky, Anumantha G. Kanthasamy, Balaraman Kalyanaraman · 2014 · Neuroscience Letters
The α7 nAChR Agonist PNU-282987 Reduces Inflammation and MPTP-Induced Nigral Dopaminergic Cell Loss in Mice
Vanessa Stuckenholz, Michael Bacher, Monika Balzer‐Geldsetzer, Daniel Alvarez‐Fischer, Wolfgang Hermann Oertel, Richard C. Dodel, Carmen Noelker · 2013 · Journal of Parkinson s Disease
Exendin-4 Treatment Improves LPS-Induced Depressive-Like Behavior Without Affecting Pro-Inflammatory Cytokines
Ventorp, Filip, Bay-Richter, Cecilie, Nagendra, Analise Sauro, Janelidze, Shorena, Matsson, Viktor Sjödahl, Lipton, Jack, Nordström, Ulrika, Westrin, Åsa, Brundin, Patrik, Brundin, Lena · 2017 · Journal of Parkinson’s Disease
Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s Disease
Leggio, Loredana, Paternò, Greta, Vivarelli, Silvia, Falzone, Giovanna G, Giachino, Carmela, Marchetti, Bianca, Iraci, Nunzio · 2021 · Aging and disease
Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra
Maxime Assous, Laurence Had‐Aissouni, Paolo Gubellini, Christophe Melon, Imane Nafia, Pascal Salin, Lydia Kerkerian‐Le Goff, Philippe Kachidian · 2014 · Neurobiology of Disease
Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease
Yongfei Zhao, Qiong Zhang, Jianying Xi, Yanhua Li, Cun‐Gen Ma, Bao‐Guo Xiao · 2015 · Journal of the Neurological Sciences
Unilateral Intrastriatal 6-Hydroxydopamine Lesion in Mice: A Closer Look into Non-Motor Phenotype and Glial Response
Bárbara Mendes-Pinheiro, Carina Soares‐Cunha, Ana Marote, Eduardo Loureiro‐Campos, Jonas Campos, Sandra Barata‐Antunes, Daniela Monteiro‐Fernandes, Diogo J. Santos, Sara Duarte‐Silva, Luísa Pinto et al. · 2021 · International Journal of Molecular Sciences
Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity
Pratap Karki, Keisha Smith, James Johnson, Michael Aschner, Eun-Sook Lee · 2014 · Neurochemistry International
Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra
Xianchang Sun, Xiaofan Ren, Lei Chen, Xian-Qi Gao, Junxia Xie, Wenfang Chen · 2015 · The Journal of Steroid Biochemistry and Molecular Biology
Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?
Giselle Charron, Évelyne Doudnikoff, Marie‐Hélène Canron, Qin Li, Céline Véga, Sébastien Marais, Jérôme Baufreton, Anne Vital, Stéphane H. R. Oliet, Erwan Bézard · 2014 · Frontiers in Aging Neuroscience
Human neuromelanin an endogenous microglial activator for dopaminergic neuron death
Wei Zhang · 2012 · Frontiers in Bioscience-Elite
Anti-neuroinflammatory Activity of Kamebakaurin From Isodon japonicus via Inhibition of c-Jun NH2-Terminal Kinase and p38 Mitogen-Activated Protein Kinase Pathway in Activated Microglial Cells
Byung-Wook Kim, Sushruta Koppula, In Su Kim, Hyung-Woo Lim, Sun-Min Hong, Sang-Don Han, Bang‐Yeon Hwang, Dong‐Kug Choi · 2011 · Journal of Pharmacological Sciences
Inflammatory Mediators as Biomarkers in Brain Disorders
Domenico Nuzzo, Pasquale Picone, Luca Caruana, Sonya Vasto, Annalisa Barera, Calogero Caruso, Marta Di Carlo · 2013 · Inflammation
3‐[(2,4‐dimethoxy)benzylidene]‐anabaseine dihydrochloride protects against 6‐hydroxydopamine‐induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats
Syuuichirou Suzuki, Jun Kawamata, Takashi Matsushita, Akihiro Matsumura, Shin Hisahara, Kazuyuki Takata, Yoshihisa Kitamura, William R. Kem, Shun Shimohama · 2012 · Journal of Neuroscience Research
Aquaporin-4 deficiency exacerbates brain oxidative damage and memory deficits induced by long-term ovarian hormone deprivation and D-galactose injection
Lei Liu, Yushan Lu, Hui Kong, Liu Li, Charles Marshall, Ming Xiao, Jiong Ding, Junying Gao, Gang Hu · 2011 · The International Journal of Neuropsychopharmacology
Dietary Polyphenols and Their Effects on Cell Biochemistry and Pathophysiology 2013
Tullia Maraldi, David Vauzour, Cristina Angeloni · 2014 · Oxidative Medicine and Cellular Longevity
Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6‐OHDA rat model of Parkinson’s disease
Agustín Anastasía, Luciana Torre, Gabriel A. de Erausquin, Daniel Hugo Mascó · 2009 · Journal of Neurochemistry
Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide
Yazmin Montserrat Flores-Martinez, Manuel A. Fernandez-Parrilla, José Ayala-Dávila, David Reyes-Corona, Víctor Manuel Blanco-Álvarez, Luis Oskar Soto-Rojas, Claudia Luna-Herrera, Juan Antonio González-Barrios, Bertha Alicia León‐Chávez, María Eugenia Gutiérrez-Castillo et al. · 2018 · Journal of Immunology Research
Small Extracellular Vesicles Secreted by Nigrostriatal Astrocytes Rescue Cell Death and Preserve Mitochondrial Function in Parkinson's Disease
Leggio, Loredana, L'Episcopo, Francesca, Magrì, Andrea, Ulloa‐Navas, María José, Paternò, Greta, Vivarelli, Silvia, Bastos, Carlos A. P., Tirolo, Cataldo, Testa, Nunzio, Caniglia, Salvatore et al. · 2022 · Advanced Healthcare Materials
Brain Protection in Schizophrenia, Mood and Cognitive Disorders
Michael S. Ritsner · 2010 · Springer eBooks
Targeting Glial Cells to Elucidate the Pathogenesis of Huntington’s Disease
Han‐Yun Hsiao, Yijuang Chern · 2010 · Molecular Neurobiology
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
Anna Rosa Carta, Augusta Pisanu, Ezio Carboni · 2011 · Parkinson s Disease
Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease
Lucian Hriţcu, Alin Stelian Ciobica, Marius Ștefan, Marius Mihăşan, Lavinia Palamiuc, Toshitaka Nabeshima · 2011 · Neuroscience Research
Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson׳s disease
Govindasamy Pushpavathi Selvakumar, Udaiyappan Janakiraman, Musthafa Mohamed Essa, Arokiasamy Justin Thenmozhi, Thamilarasan Manivasagam · 2014 · Brain Research
Glutathione S-Transferase pi Mediates MPTP-Induced c-Jun N-Terminal Kinase Activation in the Nigrostriatal Pathway
Margarida Castro‐Caldas, Andreia Neves Carvalho, Elsa Rodrigues, Colin J. Henderson, C. Roland Wolf, Maria João Gama · 2012 · Molecular Neurobiology
Altered Expression of Growth Associated Protein‐43 and Rho Kinase in Human Patients with Parkinson's Disease
Kim‐Ann Saal, Dagmar Galter, Sigrun Roeber, Mathias Bähr, Lars Tönges, Paul Lingor · 2016 · Brain Pathology
Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease
Bianca Marchetti · 2020 · Redox Biology
Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression
María Clara Pott Godoy, Carina Cintia Ferrari, Fernando Juan Pitossi · 2010 · Journal of Neuroimmunology
Outdoor work and risk for Parkinson's disease: a population-based case–control study
Line Kenborg, Christina Funch Lassen, Beate R. Ritz, Eva S. Schernhammer, Johnni Hansen, Nicole M. Gatto, Jørgen H. Olsen · 2010 · Occupational and Environmental Medicine
Role of inflammation and its miRNA based regulation in epilepsy: Implications for therapy
Arpna Srivastava, Aparna Banerjee Dixit, Jyotirmoy Banerjee, Manjari Tripathi, Poodipedi Sarat Chandra · 2015 · Clinica Chimica Acta
Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection
Heather Wilkins, Steven M. Carl, Alison C. S. Greenlief, Barry W. Festoff, Russell Howard Swerdlow · 2014 · Frontiers in Aging Neuroscience
Role of Microglia in Age-Related Changes to the Nervous System
David R. Brown · 2009 · The Scientific World JOURNAL
Near-infrared light treatment reduces astrogliosis in MPTP-treated monkeys
Nabil El Massri, Cécile Moro, Napoleon Torres-Martinez, Fannie Darlot, Diane Agay, Claude Chabrol, Daniel M. Johnstone, Jonathan Stone, Alim‐Louis Benabid, John Mitrofanis · 2016 · Experimental Brain Research
Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
Augusta Pisanu, Laura Boi, Giovanna Mulas, Saturnino Spiga, Sandro Fenu, Anna Rosa Carta · 2018 · Journal of Neural Transmission
Silibinin suppresses astroglial activation in a mouse model of acute Parkinson׳s disease by modulating the ERK and JNK signaling pathways
Yujeong Lee, Hye Jeong Chun, Kyung Moon Lee, Young‐Suk Jung, Jaewon Lee · 2015 · Brain Research
Anti-parkinsonism, hypoglycemic and anti-microbial activities of new poly fused ring heterocyclic candidates
Naif Obaid Al-Harbi, Saleh Bahashwan, Ahmed A. Fayed, Moutasem Salih Aboonq, Abd El‐Galil E. Amr · 2013 · International Journal of Biological Macromolecules
The effect of different doses of near infrared light on dopaminergic cell survival and gliosis in MPTP-treated mice
Nabil El Massri, Daniel M. Johnstone, Cassandra L. Peoples, Cécile Moro, Florian Reinhart, Napoleon Torres-Martinez, Jonathan Stone, Alim‐Louis Benabid, John Mitrofanis · 2014 · International Journal of Neuroscience
Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry
Lucas Nürnberger, René‐Maxime Gracien, Pavel Hok, Stephanie‐Michelle Hof, Udo Rüb, Helmuth Steinmetz, Rüdiger Hilker, Johannes Christian Klein, Ralf Deichmann, Simon Baudrexel · 2016 · NeuroImage Clinical
A cytokine mixture of GM‐CSF and IL‐3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6‐OHDA)‐induced Parkinsonism of rats
Mohammed Emamussalehin Choudhury, Kana Sugimoto, Madoka Kubo, Masahiro Nagai, Masahiro Nomoto, Hisaaki Takahashi, Hajime Yano, Junya Tanaka · 2011 · Brain and Behavior
Fibroblast growth factor 9 prevents MPP+‐induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro
Jui-Yen Huang, Yuting Hong, Jih‐Ing Chuang · 2009 · Journal of Neurochemistry
Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders
Mohamed Aly Zayed, Samar Sultan, Hashem O. Alsaab, Shimaa Mohammad Yousof, Ghadeer I. Alrefaei, Nouf H. Alsubhi, Saleh Alkarim, Kholoud S. Al Ghamdi, Sali Abubaker Bagabir, Ankit Jana et al. · 2022 · Cells
Antioxidant and Anti-Inflammatory Activities of Protein Hydrolysates from Mytilus Edulis and Ultrafiltration Membrane Fractions
Soo Yeon Park, Chang‐Bum Ahn, Jae‐Young Je · 2014 · Journal of Food Biochemistry